EP Patent

EP1713458B1 — Method for enhancing the bioavailability of ospemifene

Assigned to Hormos Medical Ltd · Expires 2008-03-05 · 18y expired

What this patent protects

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered …

USPTO Abstract

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Drugs covered by this patent

Patent Metadata

Patent number
EP1713458B1
Jurisdiction
EP
Classification
—
Expires
2008-03-05
Drug substance claim
No
Drug product claim
No
Assignee
Hormos Medical Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.